Viemed Healthcare - VMD Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $11.50
  • Forecasted Upside: 81.39 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$6.34
▲ +0.09 (1.44%)

This chart shows the closing price for VMD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Viemed Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VMD

Analyst Price Target is $11.50
▲ +81.39% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Viemed Healthcare in the last 3 months. The average price target is $11.50, with a high forecast of $14.00 and a low forecast of $9.00. The average price target represents a 81.39% upside from the last price of $6.34.

This chart shows the closing price for VMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Viemed Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/26/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/22/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/20/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/20/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2021Royal Bank of CanadaLower TargetOutperform$13.00 ➝ $9.00High
9/17/2021Acumen CapitalReiterated RatingBuyC$14.00High
8/4/2021Bloom BurtonUpgradeAccumulate ➝ BuyLow
3/5/2021Royal Bank of CanadaInitiated CoverageOutperform$13.00Low
10/28/2020Acumen CapitalReiterated RatingBuy$12.00High
10/19/2020Bloom BurtonReiterated RatingAccumulateHigh
5/5/2020Beacon SecuritiesReiterated RatingBuyLow
8/12/2019Lake Street CapitalBoost Target$10.00 ➝ $12.00N/A
(Data available from 8/19/2017 forward)

News Sentiment Rating

0.57 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/21/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/20/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/22/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/21/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/21/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/20/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/20/2022
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/19/2022

Current Sentiment

  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Viemed Healthcare logo
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Read More

Today's Range

Now: $6.34
Low: $6.14
High: $6.36

50 Day Range

MA: $6.47
Low: $5.24
High: $7.96

52 Week Range

Now: $6.34
Low: $3.56
High: $8.06

Volume

93,345 shs

Average Volume

174,112 shs

Market Capitalization

$251.32 million

P/E Ratio

31.70

Dividend Yield

N/A

Beta

1.62

Frequently Asked Questions

What sell-side analysts currently cover shares of Viemed Healthcare?

The following sell-side analysts have issued stock ratings on Viemed Healthcare in the last year: Acumen Capital, Royal Bank of Canada, and TheStreet.
View the latest analyst ratings for VMD.

What is the current price target for Viemed Healthcare?

2 Wall Street analysts have set twelve-month price targets for Viemed Healthcare in the last year. Their average twelve-month price target is $11.50, suggesting a possible upside of 81.4%. Acumen Capital has the highest price target set, predicting VMD will reach $14.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $9.00 for Viemed Healthcare in the next year.
View the latest price targets for VMD.

What is the current consensus analyst rating for Viemed Healthcare?

Viemed Healthcare currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VMD will outperform the market and that investors should add to their positions of Viemed Healthcare.
View the latest ratings for VMD.

What other companies compete with Viemed Healthcare?

How do I contact Viemed Healthcare's investor relations team?

Viemed Healthcare's physical mailing address is 625 East Kaliste Saloom Road, Lafayette LA, 70508. The company's listed phone number is (337) 504-3802 and its investor relations email address is [email protected] The official website for Viemed Healthcare is www.viemed.com. Learn More about contacing Viemed Healthcare investor relations.